Form 4: Bristol Myers Squibb Director Trades Shares

Julia A. Haller, a Director at Bristol Myers Squibb, reported a transaction involving the exercise of stock options and acquisition of common stock.

Summary

• Julia A. Haller, a Director at Bristol Myers Squibb, engaged in a transaction on June 15, 2026.
• She exercised stock options to acquire 20,460 shares of common stock at a price of $53.76 per share.
• Following this transaction, Ms. Haller beneficially owns 34,079 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider stock option exercise and acquisition, which does not inherently indicate positive or negative performance.

Positives

• Director Julia A. Haller exercised options, indicating potential confidence in the company's stock value.
• The transaction involved the acquisition of 20,460 shares of common stock.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a director's stock transaction.

Industry Context

StockSavvy.ai notes that Form 4 filings, like this one from Bristol Myers Squibb, are standard disclosures for insider transactions and provide transparency into executive and director stock activity, which can be a signal to the market.

Stakeholder Impact

• Shareholders: The transaction provides transparency into director stock ownership and activity, which can be a factor in investment decisions.
• Management: Demonstrates adherence to SEC reporting requirements for beneficial ownership changes.

Key Dates

Keywords

Bristol Myers Squibb, BMY, Form 4, Insider Trading, Stock Options, Director Transaction, Beneficial Ownership